Opus Genetics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$4.06

-0.25 (-5.80%)

As of Nov 14, 2:18 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 22 96%

Hold 1 4%

Sell 0 0%

Price Target

Analyst Price Target +471.7% upside

Low Target $16.63

Average Target $23.21

High Target $31.03

Current Price $4.06

Current
$4.06

Target
$23.21

$16.63 $23.21 avg $31.03

Scenario Analysis

Bear Case

$16.63

309.6%

Low target

Base Case

$23.21

+471.7%

Avg target

Bull Case

$31.03

+664.3%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$7.07

-42.6% from high

52-Week Low

$1.70

+138.8% from low

Target vs 52W High

$23.21

+228.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-12.7%
AMGN Amgen Inc	Hold	42	43%	$190.87	-59.0%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+115.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-18.6%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-92.0%
MRNA Moderna Inc	Hold	31	32%	$149.45	-33.1%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-55.2%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-33.8%